Condensed Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue, net:
Core companion animal health	$ 17,366	$ 15,649
Other vaccines, pharmaceuticals and products	3,427	3,330
Total revenue, net	20,793	18,979
Cost of revenue	12,514	11,177
Gross profit	8,279	7,802
Operating expenses:
Selling and marketing	4,945	5,125
Research and development	388	390
General and administrative	3,047	2,969
Total operating expenses	8,380	8,484
Operating income (loss)	(101)	(682)
Interest and other expense, net	16	(11)
Income (loss) before income taxes	(117)	(671)
Current tax expense	21	6
Deferred tax expense (benefit)	135	(325)
Total income tax expense (benefit)	156	(319)
Net income (loss)	(273)	(352)
Net (income) loss attributable to non-controlling interest	(465)	34
Net income (loss) attributable to Heska Corporation	$ 192	$ (386)
Basic net income (loss) per share attributable to Heska Corporation	$ 0.03	$ (0.07)
Diluted net income (loss) per share attributable to Heska Corporation	$ 0.03	$ (0.07)
Weighted average outstanding shares used to compute basic net income (loss) per share attributable to Heska Corp.	5,870	5,547
Weighted average outstanding shares used to compute diluted net income (loss) per share attributable to Heska Corp	5,985	5,547